Drug Price Proposals "Revolutionary," Notes Gellad

March 22, 2019

"The competition between companies has been on how big a rebate they can give," CP3 Director Walid Gellad told NPR's Alison Kodjak, "and the way that you give a big rebate is by increasing the list price. So the idea is to get rid of that so that companies can compete based on getting the list price lower." Other policy and economics experts weighed in on the Trump administration's proposals to lower drug prices.